nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—peripheral nervous system neoplasm	0.171	1	CbGaD
Imipramine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.133	0.236	CbGbCtD
Imipramine—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.0834	0.148	CbGbCtD
Imipramine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0394	0.0697	CbGbCtD
Imipramine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0277	0.049	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0277	0.049	CbGbCtD
Imipramine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0264	0.0467	CbGbCtD
Imipramine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.023	0.0407	CbGbCtD
Imipramine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0218	0.0385	CbGbCtD
Imipramine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0166	0.0294	CbGbCtD
Imipramine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0146	0.0257	CbGbCtD
Imipramine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.0257	CbGbCtD
Imipramine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0133	0.0235	CbGbCtD
Imipramine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0127	0.0225	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0127	0.0225	CbGbCtD
Imipramine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0113	0.02	CbGbCtD
Imipramine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0113	0.0199	CbGbCtD
Imipramine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0101	0.0178	CbGbCtD
Imipramine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00872	0.0154	CbGbCtD
Imipramine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00811	0.0143	CbGbCtD
Imipramine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00758	0.0134	CbGbCtD
Imipramine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00651	0.0115	CbGbCtD
Imipramine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00621	0.011	CbGbCtD
Imipramine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0058	0.0102	CbGbCtD
Imipramine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00569	0.0101	CbGbCtD
Imipramine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00399	0.0975	CbGeAlD
Imipramine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00388	0.00687	CbGbCtD
Imipramine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00372	0.00658	CbGbCtD
Imipramine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00366	0.00647	CbGbCtD
Imipramine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00341	0.00603	CbGbCtD
Imipramine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00412	CbGbCtD
Imipramine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00219	0.0535	CbGeAlD
Imipramine—HTR6—ganglion—peripheral nervous system neoplasm	0.00182	0.0443	CbGeAlD
Imipramine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00167	0.0407	CbGeAlD
Imipramine—HTR7—pons—peripheral nervous system neoplasm	0.00165	0.0402	CbGeAlD
Imipramine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00146	0.0356	CbGeAlD
Imipramine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00136	0.0333	CbGeAlD
Imipramine—SLC6A3—nerve—peripheral nervous system neoplasm	0.0011	0.0268	CbGeAlD
Imipramine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00109	0.0265	CbGeAlD
Imipramine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.00107	0.0261	CbGeAlD
Imipramine—KCND2—brainstem—peripheral nervous system neoplasm	0.00106	0.0259	CbGeAlD
Imipramine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00105	0.0256	CbGeAlD
Imipramine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00104	0.0254	CbGeAlD
Imipramine—HTR2A—pons—peripheral nervous system neoplasm	0.00103	0.0251	CbGeAlD
Imipramine—SLC22A3—tongue—peripheral nervous system neoplasm	0.00101	0.0247	CbGeAlD
Imipramine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000994	0.0243	CbGeAlD
Imipramine—KCND3—brainstem—peripheral nervous system neoplasm	0.000925	0.0226	CbGeAlD
Imipramine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000886	0.0217	CbGeAlD
Imipramine—HTR1A—ganglion—peripheral nervous system neoplasm	0.000883	0.0216	CbGeAlD
Imipramine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000875	0.0214	CbGeAlD
Imipramine—HTR7—nerve—peripheral nervous system neoplasm	0.000854	0.0209	CbGeAlD
Imipramine—HTR7—ganglion—peripheral nervous system neoplasm	0.000844	0.0206	CbGeAlD
Imipramine—DRD2—nerve—peripheral nervous system neoplasm	0.000808	0.0197	CbGeAlD
Imipramine—DRD2—ganglion—peripheral nervous system neoplasm	0.000798	0.0195	CbGeAlD
Imipramine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.000764	0.227	CrCbGaD
Imipramine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000743	0.0182	CbGeAlD
Imipramine—HTR2A—nerve—peripheral nervous system neoplasm	0.000533	0.013	CbGeAlD
Imipramine—HTR2A—ganglion—peripheral nervous system neoplasm	0.000526	0.0129	CbGeAlD
Imipramine—KCND2—cerebellum—peripheral nervous system neoplasm	0.000523	0.0128	CbGeAlD
Imipramine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000502	0.0123	CbGeAlD
Imipramine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000473	0.0116	CbGeAlD
Imipramine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.000472	0.14	CrCbGaD
Imipramine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000472	0.0115	CbGeAlD
Imipramine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000459	0.0112	CbGeAlD
Imipramine—KCND3—cerebellum—peripheral nervous system neoplasm	0.000456	0.0111	CbGeAlD
Imipramine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000456	0.0111	CbGeAlD
Imipramine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000432	0.129	CrCbGaD
Imipramine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.000432	0.0106	CbGeAlD
Imipramine—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000386	0.00943	CbGeAlD
Imipramine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000384	0.00938	CbGeAlD
Imipramine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00038	0.0093	CbGeAlD
Imipramine—HTR7—brainstem—peripheral nervous system neoplasm	0.000367	0.00896	CbGeAlD
Imipramine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.000354	0.105	CrCbGaD
Imipramine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000354	0.00864	CbGeAlD
Imipramine—DRD2—brainstem—peripheral nervous system neoplasm	0.000347	0.00847	CbGeAlD
Imipramine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000309	0.00756	CbGeAlD
Imipramine—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.000241	0.00588	CbGeAlD
Imipramine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000233	0.00568	CbGeAlD
Imipramine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000229	0.00559	CbGeAlD
Imipramine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000208	0.00509	CbGeAlD
Imipramine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000189	0.00462	CbGeAlD
Imipramine—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000184	0.0548	CrCbGaD
Imipramine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000181	0.00442	CbGeAlD
Imipramine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000174	0.00426	CbGeAlD
Imipramine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000171	0.00418	CbGeAlD
Imipramine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.000171	0.0508	CrCbGaD
Imipramine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000169	0.00414	CbGeAlD
Imipramine—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000168	0.00412	CbGeAlD
Imipramine—Maprotiline—ABCB1—peripheral nervous system neoplasm	0.000159	0.0472	CrCbGaD
Imipramine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000141	0.000851	CcSEcCtD
Imipramine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000141	0.000851	CcSEcCtD
Imipramine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000141	0.00085	CcSEcCtD
Imipramine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000848	CcSEcCtD
Imipramine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00014	0.000848	CcSEcCtD
Imipramine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000848	CcSEcCtD
Imipramine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000846	CcSEcCtD
Imipramine—Rash—Melphalan—peripheral nervous system neoplasm	0.00014	0.000845	CcSEcCtD
Imipramine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00014	0.000845	CcSEcCtD
Imipramine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000842	CcSEcCtD
Imipramine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.000139	0.0413	CrCbGaD
Imipramine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000837	CcSEcCtD
Imipramine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000836	CcSEcCtD
Imipramine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000835	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000138	0.000832	CcSEcCtD
Imipramine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000137	0.000828	CcSEcCtD
Imipramine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000828	CcSEcCtD
Imipramine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000818	CcSEcCtD
Imipramine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000814	CcSEcCtD
Imipramine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000814	CcSEcCtD
Imipramine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000135	0.000813	CcSEcCtD
Imipramine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000134	0.000811	CcSEcCtD
Imipramine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000134	0.00081	CcSEcCtD
Imipramine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000134	0.000807	CcSEcCtD
Imipramine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.000807	CcSEcCtD
Imipramine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000133	0.000803	CcSEcCtD
Imipramine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000803	CcSEcCtD
Imipramine—Infection—Etoposide—peripheral nervous system neoplasm	0.000132	0.000798	CcSEcCtD
Imipramine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000797	CcSEcCtD
Imipramine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000132	0.000797	CcSEcCtD
Imipramine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000132	0.000796	CcSEcCtD
Imipramine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000788	CcSEcCtD
Imipramine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00013	0.000787	CcSEcCtD
Imipramine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00013	0.000784	CcSEcCtD
Imipramine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000784	CcSEcCtD
Imipramine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00013	0.000784	CcSEcCtD
Imipramine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00013	0.000784	CcSEcCtD
Imipramine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.00013	0.00317	CbGeAlD
Imipramine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000783	CcSEcCtD
Imipramine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000129	0.00078	CcSEcCtD
Imipramine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000129	0.000777	CcSEcCtD
Imipramine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000774	CcSEcCtD
Imipramine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000766	CcSEcCtD
Imipramine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000127	0.000766	CcSEcCtD
Imipramine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000762	CcSEcCtD
Imipramine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.00076	CcSEcCtD
Imipramine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000757	CcSEcCtD
Imipramine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000752	CcSEcCtD
Imipramine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000739	CcSEcCtD
Imipramine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000732	CcSEcCtD
Imipramine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000728	CcSEcCtD
Imipramine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000726	CcSEcCtD
Imipramine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000723	CcSEcCtD
Imipramine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000723	CcSEcCtD
Imipramine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000119	0.000721	CcSEcCtD
Imipramine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000721	CcSEcCtD
Imipramine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000717	CcSEcCtD
Imipramine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000118	0.000714	CcSEcCtD
Imipramine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000118	0.000712	CcSEcCtD
Imipramine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000706	CcSEcCtD
Imipramine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000706	CcSEcCtD
Imipramine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000706	CcSEcCtD
Imipramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.000706	CcSEcCtD
Imipramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000704	CcSEcCtD
Imipramine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000116	0.0007	CcSEcCtD
Imipramine—Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.000116	0.0344	CrCbGaD
Imipramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000116	0.000698	CcSEcCtD
Imipramine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000696	CcSEcCtD
Imipramine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000115	0.000694	CcSEcCtD
Imipramine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000693	CcSEcCtD
Imipramine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000115	0.000693	CcSEcCtD
Imipramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000692	CcSEcCtD
Imipramine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000688	CcSEcCtD
Imipramine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000688	CcSEcCtD
Imipramine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000114	0.000687	CcSEcCtD
Imipramine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000113	0.00275	CbGeAlD
Imipramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.000681	CcSEcCtD
Imipramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000112	0.000679	CcSEcCtD
Imipramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000677	CcSEcCtD
Imipramine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000669	CcSEcCtD
Imipramine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000668	CcSEcCtD
Imipramine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000667	CcSEcCtD
Imipramine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000663	CcSEcCtD
Imipramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00011	0.000662	CcSEcCtD
Imipramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000109	0.000659	CcSEcCtD
Imipramine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000659	CcSEcCtD
Imipramine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000109	0.000657	CcSEcCtD
Imipramine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000109	0.000656	CcSEcCtD
Imipramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000654	CcSEcCtD
Imipramine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000653	CcSEcCtD
Imipramine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000653	CcSEcCtD
Imipramine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000653	CcSEcCtD
Imipramine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000649	CcSEcCtD
Imipramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000648	CcSEcCtD
Imipramine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000645	CcSEcCtD
Imipramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00064	CcSEcCtD
Imipramine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000106	0.000638	CcSEcCtD
Imipramine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000637	CcSEcCtD
Imipramine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000637	CcSEcCtD
Imipramine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000105	0.000635	CcSEcCtD
Imipramine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000105	0.000635	CcSEcCtD
Imipramine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000634	CcSEcCtD
Imipramine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000631	CcSEcCtD
Imipramine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000104	0.000631	CcSEcCtD
Imipramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000629	CcSEcCtD
Imipramine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000626	CcSEcCtD
Imipramine—Rash—Vincristine—peripheral nervous system neoplasm	0.000104	0.000625	CcSEcCtD
Imipramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000103	0.000625	CcSEcCtD
Imipramine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000621	CcSEcCtD
Imipramine—Headache—Vincristine—peripheral nervous system neoplasm	0.000103	0.000621	CcSEcCtD
Imipramine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000103	0.00251	CbGeAlD
Imipramine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000618	CcSEcCtD
Imipramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000611	CcSEcCtD
Imipramine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00061	CcSEcCtD
Imipramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.94e-05	0.0006	CcSEcCtD
Imipramine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000592	CcSEcCtD
Imipramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000591	CcSEcCtD
Imipramine—Nausea—Vincristine—peripheral nervous system neoplasm	9.76e-05	0.000589	CcSEcCtD
Imipramine—Clomipramine—ABCB1—peripheral nervous system neoplasm	9.75e-05	0.029	CrCbGaD
Imipramine—Flushing—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000588	CcSEcCtD
Imipramine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000588	CcSEcCtD
Imipramine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.71e-05	0.000587	CcSEcCtD
Imipramine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000584	CcSEcCtD
Imipramine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000579	CcSEcCtD
Imipramine—Asthenia—Etoposide—peripheral nervous system neoplasm	9.55e-05	0.000576	CcSEcCtD
Imipramine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000575	CcSEcCtD
Imipramine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000575	CcSEcCtD
Imipramine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000573	CcSEcCtD
Imipramine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000571	CcSEcCtD
Imipramine—Pruritus—Etoposide—peripheral nervous system neoplasm	9.41e-05	0.000568	CcSEcCtD
Imipramine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000566	CcSEcCtD
Imipramine—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.00056	CcSEcCtD
Imipramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.23e-05	0.000558	CcSEcCtD
Imipramine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000555	CcSEcCtD
Imipramine—Rash—Cisplatin—peripheral nervous system neoplasm	9.16e-05	0.000553	CcSEcCtD
Imipramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.15e-05	0.000552	CcSEcCtD
Imipramine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000552	CcSEcCtD
Imipramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.1e-05	0.00055	CcSEcCtD
Imipramine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000548	CcSEcCtD
Imipramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000547	CcSEcCtD
Imipramine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000544	CcSEcCtD
Imipramine—Flushing—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000544	CcSEcCtD
Imipramine—Trimipramine—ABCB1—peripheral nervous system neoplasm	8.97e-05	0.0267	CrCbGaD
Imipramine—Tension—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000542	CcSEcCtD
Imipramine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.00054	CcSEcCtD
Imipramine—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000536	CcSEcCtD
Imipramine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000532	CcSEcCtD
Imipramine—Dizziness—Etoposide—peripheral nervous system neoplasm	8.8e-05	0.000531	CcSEcCtD
Imipramine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.00053	CcSEcCtD
Imipramine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000529	CcSEcCtD
Imipramine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000524	CcSEcCtD
Imipramine—Promethazine—ABCB1—peripheral nervous system neoplasm	8.64e-05	0.0257	CrCbGaD
Imipramine—Nausea—Cisplatin—peripheral nervous system neoplasm	8.63e-05	0.000521	CcSEcCtD
Imipramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.00052	CcSEcCtD
Imipramine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000518	CcSEcCtD
Imipramine—Doxepin—ABCB1—peripheral nervous system neoplasm	8.55e-05	0.0254	CrCbGaD
Imipramine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000514	CcSEcCtD
Imipramine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000512	CcSEcCtD
Imipramine—Vomiting—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.000511	CcSEcCtD
Imipramine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000511	CcSEcCtD
Imipramine—Agitation—Epirubicin—peripheral nervous system neoplasm	8.4e-05	0.000507	CcSEcCtD
Imipramine—Rash—Etoposide—peripheral nervous system neoplasm	8.39e-05	0.000507	CcSEcCtD
Imipramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.38e-05	0.000506	CcSEcCtD
Imipramine—Headache—Etoposide—peripheral nervous system neoplasm	8.34e-05	0.000503	CcSEcCtD
Imipramine—Tension—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000501	CcSEcCtD
Imipramine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.0005	CcSEcCtD
Imipramine—Malaise—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000498	CcSEcCtD
Imipramine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000496	CcSEcCtD
Imipramine—Syncope—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000495	CcSEcCtD
Imipramine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000494	CcSEcCtD
Imipramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000488	CcSEcCtD
Imipramine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000485	CcSEcCtD
Imipramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000481	CcSEcCtD
Imipramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000478	CcSEcCtD
Imipramine—Nausea—Etoposide—peripheral nervous system neoplasm	7.9e-05	0.000477	CcSEcCtD
Imipramine—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000476	CcSEcCtD
Imipramine—Desipramine—ABCB1—peripheral nervous system neoplasm	7.85e-05	0.0233	CrCbGaD
Imipramine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000474	CcSEcCtD
Imipramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000469	CcSEcCtD
Imipramine—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000468	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000467	CcSEcCtD
Imipramine—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000464	CcSEcCtD
Imipramine—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.00046	CcSEcCtD
Imipramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000459	CcSEcCtD
Imipramine—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000458	CcSEcCtD
Imipramine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000457	CcSEcCtD
Imipramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000454	CcSEcCtD
Imipramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000451	CcSEcCtD
Imipramine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.00045	CcSEcCtD
Imipramine—Oedema—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.00045	CcSEcCtD
Imipramine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000449	CcSEcCtD
Imipramine—Infection—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000447	CcSEcCtD
Imipramine—ABCB1—cerebellum—peripheral nervous system neoplasm	7.39e-05	0.00181	CbGeAlD
Imipramine—Shock—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000443	CcSEcCtD
Imipramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000442	CcSEcCtD
Imipramine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000442	CcSEcCtD
Imipramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000441	CcSEcCtD
Imipramine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000441	CcSEcCtD
Imipramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.00044	CcSEcCtD
Imipramine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000437	CcSEcCtD
Imipramine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000435	CcSEcCtD
Imipramine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000433	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000432	CcSEcCtD
Imipramine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.00043	CcSEcCtD
Imipramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000429	CcSEcCtD
Imipramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.000425	CcSEcCtD
Imipramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.00042	CcSEcCtD
Imipramine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000417	CcSEcCtD
Imipramine—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000417	CcSEcCtD
Imipramine—Infection—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000414	CcSEcCtD
Imipramine—Shock—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.00041	CcSEcCtD
Imipramine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000409	CcSEcCtD
Imipramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000408	CcSEcCtD
Imipramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000407	CcSEcCtD
Imipramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000407	CcSEcCtD
Imipramine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000405	CcSEcCtD
Imipramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000404	CcSEcCtD
Imipramine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	6.69e-05	0.0199	CrCbGaD
Imipramine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000403	CcSEcCtD
Imipramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.0004	CcSEcCtD
Imipramine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	6.61e-05	0.0197	CrCbGaD
Imipramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000397	CcSEcCtD
Imipramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000396	CcSEcCtD
Imipramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000392	CcSEcCtD
Imipramine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000389	CcSEcCtD
Imipramine—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000388	CcSEcCtD
Imipramine—Constipation—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000385	CcSEcCtD
Imipramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000377	CcSEcCtD
Imipramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000374	CcSEcCtD
Imipramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000371	CcSEcCtD
Imipramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.00037	CcSEcCtD
Imipramine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000368	CcSEcCtD
Imipramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000367	CcSEcCtD
Imipramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000362	CcSEcCtD
Imipramine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.00036	CcSEcCtD
Imipramine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000359	CcSEcCtD
Imipramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000358	CcSEcCtD
Imipramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000356	CcSEcCtD
Imipramine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000356	CcSEcCtD
Imipramine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000356	CcSEcCtD
Imipramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000343	CcSEcCtD
Imipramine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000341	CcSEcCtD
Imipramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000331	CcSEcCtD
Imipramine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000329	CcSEcCtD
Imipramine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000329	CcSEcCtD
Imipramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000323	CcSEcCtD
Imipramine—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000319	CcSEcCtD
Imipramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000308	CcSEcCtD
Imipramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000299	CcSEcCtD
Imipramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000298	CcSEcCtD
Imipramine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000295	CcSEcCtD
Imipramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000286	CcSEcCtD
Imipramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000285	CcSEcCtD
Imipramine—Rash—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000284	CcSEcCtD
Imipramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000284	CcSEcCtD
Imipramine—Headache—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000282	CcSEcCtD
Imipramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000276	CcSEcCtD
Imipramine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000268	CcSEcCtD
Imipramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000265	CcSEcCtD
Imipramine—Rash—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000263	CcSEcCtD
Imipramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000263	CcSEcCtD
Imipramine—Headache—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000261	CcSEcCtD
Imipramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000248	CcSEcCtD
Imipramine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.73e-06	0.000162	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.73e-06	0.000162	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.67e-06	0.000161	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.65e-06	0.000161	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.62e-06	0.00016	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.59e-06	0.00016	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.57e-06	0.000159	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.51e-06	0.000158	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.49e-06	0.000158	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.4e-06	0.000156	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.38e-06	0.000156	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.38e-06	0.000156	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.36e-06	0.000155	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.29e-06	0.000154	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.28e-06	0.000154	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.26e-06	0.000154	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.25e-06	0.000153	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.24e-06	0.000153	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.24e-06	0.000153	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.23e-06	0.000153	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.22e-06	0.000153	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.19e-06	0.000152	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.11e-06	0.000151	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.09e-06	0.00015	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.91e-06	0.000147	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.77e-06	0.000144	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	7.73e-06	0.000144	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.7e-06	0.000143	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.61e-06	0.000141	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.59e-06	0.000141	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.58e-06	0.000141	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.57e-06	0.000141	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	7.57e-06	0.000141	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.56e-06	0.000141	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.54e-06	0.00014	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.52e-06	0.00014	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.44e-06	0.000138	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.44e-06	0.000138	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.43e-06	0.000138	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.43e-06	0.000138	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.42e-06	0.000138	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.26e-06	0.000135	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.16e-06	0.000133	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.12e-06	0.000132	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.09e-06	0.000132	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.02e-06	0.00013	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	7e-06	0.00013	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7e-06	0.00013	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.99e-06	0.00013	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.68e-06	0.000124	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	6.58e-06	0.000122	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.51e-06	0.000121	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.5e-06	0.000121	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.21e-06	0.000115	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.17e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.14e-06	0.000114	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.13e-06	0.000114	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.13e-06	0.000114	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.1e-06	0.000113	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.07e-06	0.000113	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.96e-06	0.000111	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.96e-06	0.000111	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.93e-06	0.00011	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.91e-06	0.00011	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.91e-06	0.00011	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.9e-06	0.00011	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.88e-06	0.000109	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.84e-06	0.000109	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.81e-06	0.000108	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.79e-06	0.000108	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.73e-06	0.000107	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.7e-06	0.000106	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.66e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.63e-06	0.000105	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.58e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.57e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.54e-06	0.000103	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.53e-06	0.000103	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.45e-06	0.000101	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.42e-06	0.000101	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.42e-06	0.000101	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.41e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.39e-06	0.0001	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.37e-06	9.99e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.36e-06	9.96e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.35e-06	9.95e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.35e-06	9.94e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.34e-06	9.92e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.33e-06	9.91e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.32e-06	9.88e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.27e-06	9.8e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.27e-06	9.79e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.26e-06	9.78e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.26e-06	9.77e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.25e-06	9.75e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.24e-06	9.74e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.22e-06	9.7e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.21e-06	9.68e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.17e-06	9.61e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.16e-06	9.58e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.11e-06	9.49e-05	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.07e-06	9.41e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.02e-06	9.33e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.95e-06	9.2e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.95e-06	9.19e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.89e-06	9.09e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.82e-06	8.95e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.79e-06	8.91e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.67e-06	8.68e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.61e-06	8.57e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.61e-06	8.56e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.6e-06	8.55e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.59e-06	8.53e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.58e-06	8.51e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.55e-06	8.46e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.54e-06	8.44e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.52e-06	8.39e-05	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.49e-06	8.35e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.47e-06	8.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.47e-06	8.3e-05	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.41e-06	8.2e-05	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.39e-06	8.16e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.37e-06	8.13e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.37e-06	8.11e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.35e-06	8.09e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.35e-06	8.09e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.32e-06	8.03e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.3e-06	8e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	4.24e-06	7.89e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.23e-06	7.86e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.21e-06	7.82e-05	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.2e-06	7.81e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.17e-06	7.74e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.17e-06	7.74e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.16e-06	7.74e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.15e-06	7.72e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.14e-06	7.69e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.13e-06	7.67e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.09e-06	7.6e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.08e-06	7.57e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.01e-06	7.45e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.99e-06	7.41e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.99e-06	7.41e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.92e-06	7.29e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.92e-06	7.28e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.91e-06	7.27e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.9e-06	7.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.89e-06	7.23e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.88e-06	7.2e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.85e-06	7.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.84e-06	7.14e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.84e-06	7.14e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.82e-06	7.09e-05	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.81e-06	7.09e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.81e-06	7.07e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.79e-06	7.05e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.79e-06	7.04e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.78e-06	7.03e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.78e-06	7.03e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.78e-06	7.02e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.77e-06	7.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.76e-06	6.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.75e-06	6.96e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.74e-06	6.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.73e-06	6.94e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.71e-06	6.89e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.7e-06	6.88e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.67e-06	6.81e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.65e-06	6.78e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.62e-06	6.73e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.62e-06	6.73e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.57e-06	6.64e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.52e-06	6.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.51e-06	6.53e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.49e-06	6.49e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.46e-06	6.44e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.46e-06	6.42e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-06	6.41e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.44e-06	6.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.43e-06	6.38e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.42e-06	6.36e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.42e-06	6.35e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.42e-06	6.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.4e-06	6.32e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.4e-06	6.31e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.39e-06	6.3e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.27e-06	6.08e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.25e-06	6.04e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.22e-06	5.98e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.22e-06	5.98e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.2e-06	5.94e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.2e-06	5.94e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.17e-06	5.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.16e-06	5.87e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.15e-06	5.85e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.14e-06	5.84e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.11e-06	5.78e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.1e-06	5.76e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.08e-06	5.72e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.02e-06	5.61e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3e-06	5.57e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.95e-06	5.48e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.94e-06	5.47e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.93e-06	5.45e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.93e-06	5.44e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.9e-06	5.38e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.89e-06	5.37e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.89e-06	5.37e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.82e-06	5.24e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.82e-06	5.24e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.8e-06	5.21e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.79e-06	5.18e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.72e-06	5.05e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.68e-06	4.98e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.67e-06	4.96e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.67e-06	4.96e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.63e-06	4.88e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.55e-06	4.75e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.46e-06	4.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.43e-06	4.51e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.42e-06	4.5e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.42e-06	4.49e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.41e-06	4.48e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.4e-06	4.46e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.38e-06	4.42e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.37e-06	4.41e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.37e-06	4.4e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.36e-06	4.38e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.35e-06	4.38e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.32e-06	4.31e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.31e-06	4.3e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.3e-06	4.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.3e-06	4.27e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.28e-06	4.23e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.27e-06	4.22e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.26e-06	4.19e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.09e-06	3.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.08e-06	3.86e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.05e-06	3.8e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.04e-06	3.8e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.04e-06	3.79e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.04e-06	3.78e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.03e-06	3.77e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.01e-06	3.73e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2e-06	3.72e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.58e-06	2.93e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.54e-06	2.86e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.45e-06	2.7e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	2.28e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.48e-07	1.76e-05	CbGpPWpGaD
